Best in 7 days Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 26.28 Sold : Login>>
Best in 7 days What is the recommended use and dosage of cagrilintide (GLP-1 receptor agonist) for patients with type 2 diabetes? US$ 28.28 Sold : Login>>
Best in 7 days Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity US$ 21.69 Sold : Login>>
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants - Gabe - 2024 - Diabetes, Obesity and Metabolism US$ 22.75 Min. order: 1 piece ★★★★★ 4.9 (210 reviews) Sold : Login>>
New semaglutide and cagrilintide/semaglutide results US$ 26.93 Min. order: 1 piece ★★★★★ 5.0 (14 reviews) Sold : Login>>
Novo Nordisk advances obesity candidate to late-stage program after weight loss of less than 12% US$ 25.35 Min. order: 1 piece ★★★★★ 4.2 (136 reviews) Sold : Login>>
The Obesity Wars of 2026 continue: Novo's “Miss”, Lilly's “Supremacy”, and the Quality-of-Weight-Loss Pivot US$ 29.85 Min. order: 1 piece ★★★★★ 4.9 (114 reviews) Sold : Login>>
Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application US$ 28.54 Min. order: 1 piece ★★★★★ 4.9 (198 reviews) Sold : Login>>